Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-014849

Options or other derivatives

  • Executive VP, Global R&D acquired 86,730 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fridriksdottir Hafrun · Executive VP, Global R&D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-28 Grant or award : show line 1 in the form Restricted Share Units +86,730 86,730 D
Loading xslF345X03/doc4.xml…